ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats
Novo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure sufficient supply before entering the Indian market, where obesity rates are high. Counterfeit versions of Wegovy are alr
Announcement as on 29 September 2023

Novo Nordisk India head eyes 2026 Wegovy launch, warns against copycats
He urged patients not to buy copycat versions of Wegovy, warning they could be unsafe
Announcement as on 29 September 2023

: Novo Nordisk partners with Valo Health on AI drug discovery
Novo Nordisk NVO on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and development, to focus on new cardiometabolic drug programs. The Danish pharmaceutical giant, maker of Ozempic and W
Announcement as on 25 September 2023

Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus
All three widely followed indexes closed a losing week last Friday. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite declined 1.9%, 2.9% and 3.6%, respectively. For the S&P 500 and Nasdaq, it was the
Announcement as on 25 September 2023

Where Will Novo Nordisk Stock Be in 5 Years?
Novo Nordisk (NYSE: NVO) has been growing in popularity as a result of two incredibly popular drugs, Ozempic and Wegovy. Because of the company's phenomenal growth, it has been a top buy for many investors. But the business is still growing and Novo Nordis
Announcement as on 22 September 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 41.75
  • 12Day Average: 40.74
  • 20Day Average: 39.66
  • 50Day Average: 38.86
  • 100Day Average: 46.13
  • 150Day Average: 48.06
  • 200Day Average: 50.32

NVO Indicators & signals

Indicator MACD (12,26,9)

40.84, 40.01, 0.33
Indicator MACD is in positive zone

Indicator ADX (14)

27.47, 38.93, 22.15
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.53 times
30 Thu Apr 2026 42.22 41.65 to 42.86 4.79% 1.47 times
29 Wed Apr 2026 40.29 39.70 to 40.78 -2.14% 0.95 times
28 Tue Apr 2026 41.17 41.10 to 42.08 -0.05% 0.96 times
27 Mon Apr 2026 41.19 40.55 to 41.73 0.05% 0.97 times
24 Fri Apr 2026 41.17 38.22 to 41.23 6.88% 1.2 times
23 Thu Apr 2026 38.52 38.02 to 39.20 -1.61% 0.72 times
22 Wed Apr 2026 39.15 38.85 to 39.33 -0.68% 1.02 times
21 Tue Apr 2026 39.42 38.70 to 40.20 -2.59% 1.47 times
20 Mon Apr 2026 40.47 39.75 to 40.85 -0.12% 0.47 times
17 Fri Apr 2026 40.52 40.43 to 41.29 -1% 0.77 times
16 Thu Apr 2026 40.93 40.23 to 41.66 0.29% 0.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top